Catalyst Wire Dossier Catalyst Wire Dossier

XOPENEX HFA

Levalbuterol tartrate · Lupin Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for XOPENEX HFA, covering 2006-09-15 to 2017-02-27. Get the full timeline:

Most recent: FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)

See pricing